<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Zhang B</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Respiratory failure (RF) is the leading cause of death in chronic obstructive pulmonary disease (COPD), yet reliable biomarkers for early risk stratification remain unclear. Circulating C-reactive protein (CRP) reflects systemic inflammation, but its prognostic value for incident RF in COPD is controversial.&lt;h4>Methods&lt;/h4>A total of 38 933 patients from the UK Biobank with the ratio of Forced Expiratory Volume in 1 second to Forced Vital Capacity (FEV&lt;sub>1&lt;/sub>/FVC) &lt; 0.70 but without RF at baseline were included, and a maximum of 17.87 years of follow-up was conducted. Participants were divided into five subgroups based on serum CRP concentration. Kaplan-Meier survival analysis was utilised to assess the correlation between CRP stratification, incident RF, all-cause mortality, and COPD-induced mortality. The dose-response relationship between CRP concentration and incident RF was investigated using Cox proportional hazards regression.&lt;h4>Results&lt;/h4>Kaplan-Meier curves showed statistically significant differences in RF across all subgroups throughout the entire follow-up period. Additionally, significant differences were observed between groups concerning all-cause mortality and COPD-induced mortality as well. The Cox proportional hazards model demonstrated a clear dose-response relationship between CRP concentration and RF, even after adjustment for several clinical covariates and systemic inflammation index.&lt;h4>Conclusions&lt;/h4>Serum CRP concentration may forecast a high risk of incident RF in patients with COPD, indicating further research on the threshold.</pubmed_abstract><journal>Journal of global health</journal><pagination>04061</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12947716</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>C-reactive protein predicts respiratory failure in chronic obstructive pulmonary disease: a cohort analysis from the UK Biobank.</pubmed_title><pmcid>PMC12947716</pmcid><pubmed_authors>Zhao R</pubmed_authors><pubmed_authors>Jiang Q</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors><pubmed_authors>Dai Z</pubmed_authors></additional><is_claimable>false</is_claimable><name>C-reactive protein predicts respiratory failure in chronic obstructive pulmonary disease: a cohort analysis from the UK Biobank.</name><description>&lt;h4>Background&lt;/h4>Respiratory failure (RF) is the leading cause of death in chronic obstructive pulmonary disease (COPD), yet reliable biomarkers for early risk stratification remain unclear. Circulating C-reactive protein (CRP) reflects systemic inflammation, but its prognostic value for incident RF in COPD is controversial.&lt;h4>Methods&lt;/h4>A total of 38 933 patients from the UK Biobank with the ratio of Forced Expiratory Volume in 1 second to Forced Vital Capacity (FEV&lt;sub>1&lt;/sub>/FVC) &lt; 0.70 but without RF at baseline were included, and a maximum of 17.87 years of follow-up was conducted. Participants were divided into five subgroups based on serum CRP concentration. Kaplan-Meier survival analysis was utilised to assess the correlation between CRP stratification, incident RF, all-cause mortality, and COPD-induced mortality. The dose-response relationship between CRP concentration and incident RF was investigated using Cox proportional hazards regression.&lt;h4>Results&lt;/h4>Kaplan-Meier curves showed statistically significant differences in RF across all subgroups throughout the entire follow-up period. Additionally, significant differences were observed between groups concerning all-cause mortality and COPD-induced mortality as well. The Cox proportional hazards model demonstrated a clear dose-response relationship between CRP concentration and RF, even after adjustment for several clinical covariates and systemic inflammation index.&lt;h4>Conclusions&lt;/h4>Serum CRP concentration may forecast a high risk of incident RF in patients with COPD, indicating further research on the threshold.</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T22:20:26.265Z</modification><creation>2026-07-11T03:12:10.219Z</creation></dates><accession>S-EPMC12947716</accession><cross_references><pubmed>41757812</pubmed><doi>10.7189/jogh.16.04061</doi></cross_references></HashMap>